Research articlePublished 2017
Biological Evidences of Hepatocellular Carcinoma Treatment with 1,3,4-oxadiazole-2-thiol as Anticancer Agent
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Purpose: In recent years, identification of novel potent, selective, and less toxic anticancer agents remains one of the most pressing health problems. This research aimed to in vivo illustration of 1,3,4-oxadiazole-2-thiol (OXD-T) anticancer activities as a discovery of the treatment of Hepatocellular Carcinoma (HCC) of Albino rats. Methods: Hepatocellular carcinoma was induced by 3,3’-Diamino benzidine for three months, three times per week. The post treatment of HCC induced rats was carried out with OXD-T therapeutic (300 mg/kg. b.wt.) and half therapeutic doses (150 mg/kg b.wt.) of administration. Biochemical parameters and comet assay were assessed to evaluate the efficiency of OXD-T treatment on the HCC induced animal. Results: The administration of 1,3,4-oxadiazole-2-thiol (OXD-T) with therapeutic dose and half therapeutic dose to hepatocellular carcinoma (HCC) induced rats affected the biochemical values as biomarkers; prothrombin induced by vitamin K absence-II (PIVKA-II) and lactate dehydrogenase LDH. Also, serum enzymes; AST, ALT, GGT and Albumin. Furthermore, OXD-T affected the DNA fragmentation parameters (tail length, tail moment, % DNA in tail and % DNA in head of comet). OXD-T therapeutic administration revealed highly significant decreases in the biochemical values and DNA fragmentation parameters more than half dose of OXD-T treatment. Conclusion: OXD-T antimetabolite with different therapeutic doses of administration affected the growth of hepatocellular carcinoma.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biomolecular Research & Therapeutics
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “Mohamed S Gabry”
- BylineArticles whose byline prints “Galal H Elgemeie”
- BylineArticles whose byline prints “Nahed S Basseli”
- BylineArticles whose byline prints “Samuel T Melek”
- BylineArticles whose byline prints “Saadia E Hafez”
- BylineArticles whose byline prints “Omar A Farid”
- BylineArticles whose byline prints “Shimaa S Abdelhady”
